Researchers compared QOL and other outcomes between patients with endometrial cancer who took short-course adjuvant VCB and ...

Tumor mutational burden and T-cell inflamed 18-gene expression profile were associated with better outcomes in the Keytruda arm. PTEN loss and BRCA/HRD status showed positive associations with ...

Regarding safety, any-grade treatment-related side effects occurred in 96% of those in the ADC-alone arm (50 patients), 97.9% of those in the ADC/Femara arm (48 patients) and 95.8% of those in the ...

Patients were randomly assigned to receive either SHR-A1811 (n = 87; arm A), the combination of SHR-A1811 plus pyrotinib, a tyrosine kinase inhibitor approved in China (n = 88; arm B), or ...

Various biomarkers, including T-cell inflamed 18-gene expression profile, were positively prognostic for improved pathologic complete response (pCR) and event-free survival (EFS), with or without the ...

Introduction: Pediatric sarcomas, including osteosarcoma (OS), Ewing sarcoma (EwS) and rhabdomyosarcoma (RMS) carry low somatic mutational burden and low MHC-I expression, posing a challenge for T ...

Qualcomm’s 2024 debut of new Arm processors for Windows laptops was arguably the most important PC hardware announcement since the introduction of Intel’s 486 processors in 1989. Just as that ...

A recent analysis reveals that the incidence rates of soft tissue sarcomas—cancers in muscle, fat, blood vessels, nerves, and tendons—are lower in young U.S. active-duty military servicemen ...

A recent analysis reveals that the incidence rates of soft tissue sarcomas-;cancers in muscle, fat, blood vessels, nerves, and tendons-;are lower in young U.S. active-duty military servicemen ...

Google Drive beta software now available for Snapdragon processors Only available for Windows 11 (and presumably onward) Marks a trend of increased support for ARM Google has confirmed machines ...

There was no significant difference in failure-free survival between the ibrutinib arm and the transplant-ibrutinib arm. Ibrutinib-containing regimens may be the “preferred” first-line ...

At maintenance cycle 34, there were 254 patients in the daratumumab group and 164 in the control arm on study. Results showed the following 1: Compliance on the questionnaires was above 94% on all ...